Clinical Trial Update: Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms [NA]

View source ↗

Summary

The clinical trial evaluating vagus nerve stimulation for COVID-19 respiratory symptoms was terminated, and results have been posted (May 1, 2024).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome
• Respiratory Failure
• Respiratory Syndrome

Drugs mentioned

• Nerve stimulation device (investigational)

Snippet

Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | Conditions: COVID, Corona Virus Infection | NA | Status: TERMINATED | Results posted: 2024-05-01